Humanized IL-3/GM-CSF knockout mice sustain human hematopoietic cells and form human immune granulomas for pathogen infection studies.
A thrombopoietin-FLT3 ligand fusion polypeptide extends circulation time while boosting platelet production and hematopoietic cell survival.
A staged affinity, mixed-mode, and cation exchange sequence removes sulfide variants from refolded Fc-peptide fusion proteins while preserving yield.